TY - JOUR AU - Maris, J. M. AU - Hogarty, M. D. AU - Bagatell, R. AU - Cohn, S. L. PY - 2007 DA - 2007// TI - Neuroblastoma JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60983-0 DO - 10.1016/S0140-6736(07)60983-0 ID - Maris2007 ER - TY - JOUR AU - Brodeur, G. M. PY - 2003 DA - 2003// TI - Neuroblastoma: biological insights into a clinical enigma JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1014 DO - 10.1038/nrc1014 ID - Brodeur2003 ER - TY - JOUR AU - Casciano, I. AU - Mazzocco, K. AU - Boni, L. AU - Pagnan, G. AU - Banelli, B. AU - Allemanni, G. PY - 2002 DA - 2002// TI - Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients JO - Cell Death Differ VL - 9 UR - https://doi.org/10.1038/sj.cdd.4400993 DO - 10.1038/sj.cdd.4400993 ID - Casciano2002 ER - TY - JOUR AU - Cohn, S. L. AU - Pearson, A. D. J. AU - London, W. B. AU - Monclair, T. AU - Ambros, P. F. AU - Brodeur, G. M. PY - 2009 DA - 2009// TI - The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.16.6785 DO - 10.1200/JCO.2008.16.6785 ID - Cohn2009 ER - TY - JOUR AU - Strieder, V. AU - Lutz, W. PY - 2003 DA - 2003// TI - E2F proteins regulate MYCN expression in neuroblastomas JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M207596200 DO - 10.1074/jbc.M207596200 ID - Strieder2003 ER - TY - JOUR AU - Mosse, Y. P. AU - Wood, A. AU - Maris, J. M. PY - 2009 DA - 2009// TI - Inhibition of ALK signaling for cancer therapy JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-2762 DO - 10.1158/1078-0432.CCR-08-2762 ID - Mosse2009 ER - TY - JOUR AU - Holzel, M. AU - Huang, S. AU - Koster, J. AU - Ora, I. AU - Lakeman, A. AU - Caron, H. PY - 2010 DA - 2010// TI - NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome JO - Cell VL - 142 UR - https://doi.org/10.1016/j.cell.2010.06.004 DO - 10.1016/j.cell.2010.06.004 ID - Holzel2010 ER - TY - JOUR AU - Goldman, S. C. AU - Chen, C. Y. AU - Lansing, T. J. AU - Gilmer, T. M. AU - Kastan, M. B. PY - 1996 DA - 1996// TI - The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization JO - Am J Pathol VL - 148 ID - Goldman1996 ER - TY - JOUR AU - Fesik, S. W. PY - 2005 DA - 2005// TI - Promoting apoptosis as a strategy for cancer drug discovery JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1736 DO - 10.1038/nrc1736 ID - Fesik2005 ER - TY - JOUR AU - Eleveld, T. F. AU - Oldridge, D. A. AU - Bernard, V. AU - Koster, J. AU - Daage, L. C. AU - Diskin, S. J. PY - 2015 DA - 2015// TI - Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations JO - Nat Genet VL - 47 UR - https://doi.org/10.1038/ng.3333 DO - 10.1038/ng.3333 ID - Eleveld2015 ER - TY - JOUR AU - Schramm, A. AU - Koster, J. AU - Assenov, Y. AU - Althoff, K. AU - Peifer, M. AU - Mahlow, E. PY - 2015 DA - 2015// TI - Mutational dynamics between primary and relapse neuroblastomas JO - Nat Genet VL - 47 UR - https://doi.org/10.1038/ng.3349 DO - 10.1038/ng.3349 ID - Schramm2015 ER - TY - JOUR AU - Poortinga, G. AU - Quinn, L. M. AU - Hannan, R. D. PY - 2015 DA - 2015// TI - Targeting RNA polymerase I to treat MYC-driven cancer JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.13 DO - 10.1038/onc.2014.13 ID - Poortinga2015 ER - TY - STD TI - Gentilella A, Kozma SC, Thomas G. A liaison between mTOR signaling, ribosome biogenesis and cancer. Biochimica et biophysica acta. 2015. doi:10.1016/j.bbagrm.2015.02.005. ID - ref13 ER - TY - JOUR AU - Ruggero, D. AU - Pandolfi, P. P. PY - 2003 DA - 2003// TI - Does the ribosome translate cancer? JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1015 DO - 10.1038/nrc1015 ID - Ruggero2003 ER - TY - JOUR AU - Ruggero, D. PY - 2012 DA - 2012// TI - Revisiting the nucleolus: from marker to dynamic integrator of cancer signaling JO - Sci Signal VL - 5 UR - https://doi.org/10.1126/scisignal.2003477 DO - 10.1126/scisignal.2003477 ID - Ruggero2012 ER - TY - JOUR AU - Thomas, G. PY - 2000 DA - 2000// TI - An encore for ribosome biogenesis in the control of cell proliferation JO - Nat Cell Biol VL - 2 UR - https://doi.org/10.1038/35010581 DO - 10.1038/35010581 ID - Thomas2000 ER - TY - JOUR AU - Riggelen, J. AU - Yetil, A. AU - Felsher, D. W. PY - 2010 DA - 2010// TI - MYC as a regulator of ribosome biogenesis and protein synthesis JO - Nat Rev Cancer VL - 10 UR - https://doi.org/10.1038/nrc2819 DO - 10.1038/nrc2819 ID - Riggelen2010 ER - TY - JOUR AU - Boon, K. AU - Caron, H. N. AU - Asperen, R. AU - Valentijn, L. AU - Hermus, M. C. AU - Sluis, P. PY - 2001 DA - 2001// TI - N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis JO - EMBO J VL - 20 UR - https://doi.org/10.1093/emboj/20.6.1383 DO - 10.1093/emboj/20.6.1383 ID - Boon2001 ER - TY - JOUR AU - Bywater, M. J. AU - Poortinga, G. AU - Sanij, E. AU - Hein, N. AU - Peck, A. AU - Cullinane, C. PY - 2012 DA - 2012// TI - Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53 JO - Cancer Cell VL - 22 UR - https://doi.org/10.1016/j.ccr.2012.05.019 DO - 10.1016/j.ccr.2012.05.019 ID - Bywater2012 ER - TY - JOUR AU - Hollstein, U. PY - 1974 DA - 1974// TI - Actinomycin. Chemistry and mechanism of action JO - Chem Rev VL - 74 UR - https://doi.org/10.1021/cr60292a002 DO - 10.1021/cr60292a002 ID - Hollstein1974 ER - TY - JOUR AU - Malogolowkin, M. AU - Cotton, C. A. AU - Green, D. M. AU - Breslow, N. E. AU - Perlman, E. AU - Miser, J. PY - 2008 DA - 2008// TI - Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group JO - Pediatr Blood Cancer VL - 50 UR - https://doi.org/10.1002/pbc.21267 DO - 10.1002/pbc.21267 ID - Malogolowkin2008 ER - TY - JOUR AU - Jaffe, N. AU - Paed, D. AU - Traggis, D. AU - Salian, S. AU - Cassady, J. R. PY - 1976 DA - 1976// TI - Improved outlook for Ewing’s sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy JO - Cancer VL - 38 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - Jaffe1976 ER - TY - JOUR AU - Perry, R. P. AU - Kelley, D. E. PY - 1970 DA - 1970// TI - Inhibition of RNA synthesis by actinomycin D: characteristic dose–response of different RNA species JO - J Cell Physiol VL - 76 UR - https://doi.org/10.1002/jcp.1040760202 DO - 10.1002/jcp.1040760202 ID - Perry1970 ER - TY - JOUR AU - Donati, G. AU - Peddigari, S. AU - Mercer, C. A. AU - Thomas, G. PY - 2013 DA - 2013// TI - 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint JO - Cell Rep VL - 4 UR - https://doi.org/10.1016/j.celrep.2013.05.045 DO - 10.1016/j.celrep.2013.05.045 ID - Donati2013 ER - TY - JOUR AU - Merkel, O. AU - Wacht, N. AU - Sifft, E. AU - Melchardt, T. AU - Hamacher, F. AU - Kocher, T. PY - 2012 DA - 2012// TI - Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2012.147 DO - 10.1038/leu.2012.147 ID - Merkel2012 ER - TY - JOUR AU - Fouladi, M. AU - Park, J. R. AU - Stewart, C. F. AU - Gilbertson, R. J. AU - Schaiquevich, P. AU - Sun, J. PY - 2010 DA - 2010// TI - Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children’s Oncology Group phase I consortium report JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.9119 DO - 10.1200/JCO.2009.25.9119 ID - Fouladi2010 ER - TY - JOUR AU - Francisco, R. AU - Perez-Perarnau, A. AU - Cortes, C. AU - Gil, J. AU - Tauler, A. AU - Ambrosio, S. PY - 2012 DA - 2012// TI - Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells JO - Cancer Lett VL - 318 UR - https://doi.org/10.1016/j.canlet.2011.11.036 DO - 10.1016/j.canlet.2011.11.036 ID - Francisco2012 ER - TY - JOUR AU - Lutz, W. AU - Stohr, M. AU - Schurmann, J. AU - Wenzel, A. AU - Lohr, A. AU - Schwab, M. PY - 1996 DA - 1996// TI - Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells JO - Oncogene VL - 13 ID - Lutz1996 ER - TY - JOUR AU - Moll, U. M. AU - Petrenko, O. PY - 2003 DA - 2003// TI - The MDM2-p53 interaction JO - Mol Cancer Res VL - 1 ID - Moll2003 ER - TY - JOUR AU - Klionsky, D. J. AU - Abeliovich, H. AU - Agostinis, P. AU - Agrawal, D. K. AU - Aliev, G. AU - Askew, D. S. PY - 2008 DA - 2008// TI - Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes JO - Autophagy VL - 4 UR - https://doi.org/10.4161/auto.5338 DO - 10.4161/auto.5338 ID - Klionsky2008 ER - TY - JOUR AU - Marks, P. A. AU - Xu, W. S. PY - 2009 DA - 2009// TI - Histone deacetylase inhibitors: potential in cancer therapy JO - J Cell Biochem VL - 107 UR - https://doi.org/10.1002/jcb.22185 DO - 10.1002/jcb.22185 ID - Marks2009 ER - TY - JOUR AU - Yoon, M. K. AU - Ha, J. H. AU - Lee, M. S. AU - Chi, S. W. PY - 2015 DA - 2015// TI - Structure and apoptotic function of p73 JO - BMB Rep VL - 48 UR - https://doi.org/10.5483/BMBRep.2015.48.2.255 DO - 10.5483/BMBRep.2015.48.2.255 ID - Yoon2015 ER - TY - JOUR AU - Lau, L. M. AU - Nugent, J. K. AU - Zhao, X. AU - Irwin, M. S. PY - 2008 DA - 2008// TI - HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function JO - Oncogene VL - 27 UR - https://doi.org/10.1038/sj.onc.1210707 DO - 10.1038/sj.onc.1210707 ID - Lau2008 ER - TY - JOUR AU - Peirce, S. K. AU - Findley, H. W. PY - 2009 DA - 2009// TI - High level MycN expression in non-MYCN amplified neuroblastoma is induced by the combination treatment nutlin-3 and doxorubicin and enhances chemosensitivity JO - Oncol Rep VL - 22 UR - https://doi.org/10.3892/or_00000586 DO - 10.3892/or_00000586 ID - Peirce2009 ER - TY - JOUR AU - Mischo, H. E. AU - Hemmerich, P. AU - Grosse, F. AU - Zhang, S. PY - 2005 DA - 2005// TI - Actinomycin D induces histone gamma-H2AX foci and complex formation of gamma-H2AX with Ku70 and nuclear DNA helicase II JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M411444200 DO - 10.1074/jbc.M411444200 ID - Mischo2005 ER - TY - JOUR AU - Matthay, K. K. AU - Villablanca, J. G. AU - Seeger, R. C. AU - Stram, D. O. AU - Harris, R. E. AU - Ramsay, N. K. PY - 1999 DA - 1999// TI - Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199910143411601 DO - 10.1056/NEJM199910143411601 ID - Matthay1999 ER - TY - JOUR AU - Maerken, T. AU - Rihani, A. AU - Dreidax, D. AU - Clercq, S. AU - Yigit, N. AU - Marine, J. C. PY - 2011 DA - 2011// TI - Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3 JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-10-1090 DO - 10.1158/1535-7163.MCT-10-1090 ID - Maerken2011 ER - TY - JOUR AU - Ozaki, T. AU - Hosoda, M. AU - Miyazaki, K. AU - Hayashi, S. AU - Watanabe, K. AU - Nakagawa, T. PY - 2005 DA - 2005// TI - Functional implication of p73 protein stability in neuronal cell survival and death JO - Cancer Lett VL - 228 UR - https://doi.org/10.1016/j.canlet.2004.12.050 DO - 10.1016/j.canlet.2004.12.050 ID - Ozaki2005 ER - TY - JOUR AU - Fumagalli, S. AU - Ivanenkov, V. V. AU - Teng, T. AU - Thomas, G. PY - 2012 DA - 2012// TI - Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint JO - Genes Dev VL - 26 UR - https://doi.org/10.1101/gad.189951.112 DO - 10.1101/gad.189951.112 ID - Fumagalli2012 ER - TY - JOUR AU - Gomez-Santos, C. AU - Ferrer, I. AU - Santidrian, A. F. AU - Barrachina, M. AU - Gil, J. AU - Ambrosio, S. PY - 2003 DA - 2003// TI - Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells JO - J Neurosci Res VL - 73 UR - https://doi.org/10.1002/jnr.10663 DO - 10.1002/jnr.10663 ID - Gomez-Santos2003 ER - TY - JOUR AU - Gamble, L. D. AU - Kees, U. R. AU - Tweddle, D. A. AU - Lunec, J. PY - 2012 DA - 2012// TI - MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63 JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.270 DO - 10.1038/onc.2011.270 ID - Gamble2012 ER - TY - JOUR AU - Hill, C. R. AU - Cole, M. AU - Errington, J. AU - Malik, G. AU - Boddy, A. V. AU - Veal, G. J. PY - 2014 DA - 2014// TI - Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer JO - Clin Pharmacokinet VL - 53 UR - https://doi.org/10.1007/s40262-014-0153-2 DO - 10.1007/s40262-014-0153-2 ID - Hill2014 ER - TY - JOUR AU - Witt, O. AU - Milde, T. AU - Deubzer, H. E. AU - Oehme, I. AU - Witt, R. AU - Kulozik, A. PY - 2012 DA - 2012// TI - Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma or leukemia JO - Klin Padiatr VL - 224 UR - https://doi.org/10.1055/s-0032-1323692 DO - 10.1055/s-0032-1323692 ID - Witt2012 ER - TY - JOUR AU - Ouwehand, K. AU - Ruijter, A. J. AU - Bree, C. AU - Caron, H. N. AU - Kuilenburg, A. B. PY - 2005 DA - 2005// TI - Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins JO - FEBS Lett VL - 579 UR - https://doi.org/10.1016/j.febslet.2005.01.058 DO - 10.1016/j.febslet.2005.01.058 ID - Ouwehand2005 ER - TY - JOUR AU - Huang, L. AU - Sowa, Y. AU - Sakai, T. AU - Pardee, A. B. PY - 2000 DA - 2000// TI - Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203963 DO - 10.1038/sj.onc.1203963 ID - Huang2000 ER - TY - JOUR AU - Peart, M. J. AU - Smyth, G. K. AU - Laar, R. K. AU - Bowtell, D. D. AU - Richon, V. M. AU - Marks, P. A. PY - 2005 DA - 2005// TI - Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0500369102 DO - 10.1073/pnas.0500369102 ID - Peart2005 ER - TY - JOUR AU - Hahn, C. K. AU - Ross, K. N. AU - Warrington, I. M. AU - Mazitschek, R. AU - Kanegai, C. M. AU - Wright, R. D. PY - 2008 DA - 2008// TI - Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0710413105 DO - 10.1073/pnas.0710413105 ID - Hahn2008 ER - TY - JOUR AU - De los Santos, M. AU - Zambrano, A. AU - Aranda, A. PY - 2007 DA - 2007// TI - Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells JO - Mol Cancer Ther VL - 6 UR - https://doi.org/10.1158/1535-7163.MCT-06-0623 DO - 10.1158/1535-7163.MCT-06-0623 ID - De los Santos2007 ER - TY - JOUR AU - Carr-Wilkinson, J. AU - O’Toole, K. AU - Wood, K. M. AU - Challen, C. C. AU - Baker, A. G. AU - Board, J. R. PY - 2010 DA - 2010// TI - High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-1865 DO - 10.1158/1078-0432.CCR-09-1865 ID - Carr-Wilkinson2010 ER - TY - JOUR AU - Morgado-Palacin, L. AU - Llanos, S. AU - Urbano-Cuadrado, M. AU - Blanco-Aparicio, C. AU - Megias, D. AU - Pastor, J. PY - 2014 DA - 2014// TI - Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway JO - Carcinogenesis VL - 35 UR - https://doi.org/10.1093/carcin/bgu220 DO - 10.1093/carcin/bgu220 ID - Morgado-Palacin2014 ER - TY - JOUR AU - Caporale, D. M. AU - Bobbio, A. AU - Accordino, R. AU - Ampollini, L. AU - Internullo, E. AU - Cattelani, L. PY - 2003 DA - 2003// TI - Ectopic mediastinal parathyroid adenoma JO - Acta Biomed VL - 74 ID - Caporale2003 ER - TY - JOUR AU - Real, S. AU - Meo-Evoli, N. AU - Espada, L. AU - Tauler, A. PY - 2011 DA - 2011// TI - E2F1 regulates cellular growth by mTORC1 signaling JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0016163 DO - 10.1371/journal.pone.0016163 ID - Real2011 ER - TY - JOUR AU - Chou, T. -. C. PY - 2006 DA - 2006// TI - Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies JO - Pharmacol Rev VL - 58 UR - https://doi.org/10.1124/pr.58.3.10 DO - 10.1124/pr.58.3.10 ID - Chou2006 ER -